Reduced mind wandering in patients with Parkinson's disease
Mind Wandering (MW) refers to the process of disengaging from the immediate external environment and participating in internally driven mentation. This process has been suggested to be supported by a distributed set of brain regions, collectively referred to as the Default Mode Network (DMN). Recent...
Gespeichert in:
Veröffentlicht in: | Parkinsonism & related disorders 2017-11, Vol.44 (44), p.38-43 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 43 |
---|---|
container_issue | 44 |
container_start_page | 38 |
container_title | Parkinsonism & related disorders |
container_volume | 44 |
creator | Geffen, Tal Thaler, Avner Gilam, Gadi Ben Simon, Eti Sarid, Nimrod Gurevich, Tanya Giladi, Nir Shabtai, Hertzel Zitser, Jennifer Schilman, Eduardo A. Sharon, Haggai |
description | Mind Wandering (MW) refers to the process of disengaging from the immediate external environment and participating in internally driven mentation. This process has been suggested to be supported by a distributed set of brain regions, collectively referred to as the Default Mode Network (DMN). Recently, reduced recruitment and connectivity of the DMN has been described in Parkinson's disease (PD) patients compared to healthy controls. We thus aimed to explore whether PD patients with normal cognitive test scores show differential MW capabilities compared to healthy controls.
Thirty PD patients and thirty age-matched controls, all with a Montreal cognitive assessment (MoCA) score of 26 or above, performed a novel yet validated thought-sampling paradigm used to assess the frequency and extent of MW irrespective of cognitive load in which participants were asked to observe a series of geometric shapes and describe their thoughts after watching them. Shapes were presented one at a time for varying durations across nine trials.
PD patients showed significantly less MW compared to the control. ANCOVA revealed a significant interaction indicating that the difference in MW scores was driven by trials with short stimulus presentation times.
These findings provide evidence for decreased MW in PD patients. We propose that this is due to difficulties in performing MW within short time frames.
•We examined whether Parkinson's patients display reduced mind wondering regardless of cognitive capabilities.•We found significantly less mind wandering in patients relative to healthy controls.•This difference was driven by trials with short stimulus presentation time.•This study is a potential first step in characterizing a new non-motor symptom in Parkinson's disease. |
doi_str_mv | 10.1016/j.parkreldis.2017.08.030 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1936622826</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1353802017303255</els_id><sourcerecordid>1936622826</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-2b67b5edcbf3b0ad5254530e12cf1be8b322c7f04ad6a629f23ae12e60c676e13</originalsourceid><addsrcrecordid>eNqF0MtKxDAUBuAgipfRV5DudNN6ktgkgysVbyAoouuQy-mYsdPWpKP49kbGy9JVAvlP_sNHSEGhokDF0bwaTHyJ2PqQKgZUVqAq4LBGtqmSvKwpE-v5zmteKmCwRXZSmgOArIFvki2mlJSqltvk5AH90qEvFqHzxbvpPMbQzYrQFYMZA3ZjKt7D-Fzc58LQpb47SEVuRZNwl2w0pk24931OyNPlxeP5dXl7d3VzfnpbOj6VY8mskLZG72zDLRhfs_q45oCUuYZaVJYz5mQDx8YLI9i0YdzkRxTghBRI-YQcrv4dYv-6xDTqRUgO29Z02C-TplMuBGOKiRxVq6iLfUoRGz3EsDDxQ1PQX3R6rv_o9BedBqUzXR7d_25Z2gX638Efq79AmHmnbbBt6GfRDM_B6SnL1BNytgpgxngLGHVyWTDrhohu1L4P_6_xCf_lj3A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1936622826</pqid></control><display><type>article</type><title>Reduced mind wandering in patients with Parkinson's disease</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Geffen, Tal ; Thaler, Avner ; Gilam, Gadi ; Ben Simon, Eti ; Sarid, Nimrod ; Gurevich, Tanya ; Giladi, Nir ; Shabtai, Hertzel ; Zitser, Jennifer ; Schilman, Eduardo A. ; Sharon, Haggai</creator><creatorcontrib>Geffen, Tal ; Thaler, Avner ; Gilam, Gadi ; Ben Simon, Eti ; Sarid, Nimrod ; Gurevich, Tanya ; Giladi, Nir ; Shabtai, Hertzel ; Zitser, Jennifer ; Schilman, Eduardo A. ; Sharon, Haggai</creatorcontrib><description>Mind Wandering (MW) refers to the process of disengaging from the immediate external environment and participating in internally driven mentation. This process has been suggested to be supported by a distributed set of brain regions, collectively referred to as the Default Mode Network (DMN). Recently, reduced recruitment and connectivity of the DMN has been described in Parkinson's disease (PD) patients compared to healthy controls. We thus aimed to explore whether PD patients with normal cognitive test scores show differential MW capabilities compared to healthy controls.
Thirty PD patients and thirty age-matched controls, all with a Montreal cognitive assessment (MoCA) score of 26 or above, performed a novel yet validated thought-sampling paradigm used to assess the frequency and extent of MW irrespective of cognitive load in which participants were asked to observe a series of geometric shapes and describe their thoughts after watching them. Shapes were presented one at a time for varying durations across nine trials.
PD patients showed significantly less MW compared to the control. ANCOVA revealed a significant interaction indicating that the difference in MW scores was driven by trials with short stimulus presentation times.
These findings provide evidence for decreased MW in PD patients. We propose that this is due to difficulties in performing MW within short time frames.
•We examined whether Parkinson's patients display reduced mind wondering regardless of cognitive capabilities.•We found significantly less mind wandering in patients relative to healthy controls.•This difference was driven by trials with short stimulus presentation time.•This study is a potential first step in characterizing a new non-motor symptom in Parkinson's disease.</description><identifier>ISSN: 1353-8020</identifier><identifier>EISSN: 1873-5126</identifier><identifier>DOI: 10.1016/j.parkreldis.2017.08.030</identifier><identifier>PMID: 28877857</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Aged ; Brain Mapping ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Mind wandering ; Parkinson Disease - psychology ; Parkinson's disease ; Thinking</subject><ispartof>Parkinsonism & related disorders, 2017-11, Vol.44 (44), p.38-43</ispartof><rights>2017</rights><rights>Copyright © 2017. Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-2b67b5edcbf3b0ad5254530e12cf1be8b322c7f04ad6a629f23ae12e60c676e13</citedby><cites>FETCH-LOGICAL-c397t-2b67b5edcbf3b0ad5254530e12cf1be8b322c7f04ad6a629f23ae12e60c676e13</cites><orcidid>0000-0002-3862-8288</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1353802017303255$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://igdc.huji.ac.il/home/Maagar/Details.aspx?AN=9235$$D View record in IGDC$$Hfree_for_read</backlink><backlink>$$Uhttps://www.sciencedirect.com/science/article/pii/S1353802017303255$$D View full text (Access may be restricted)$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28877857$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Geffen, Tal</creatorcontrib><creatorcontrib>Thaler, Avner</creatorcontrib><creatorcontrib>Gilam, Gadi</creatorcontrib><creatorcontrib>Ben Simon, Eti</creatorcontrib><creatorcontrib>Sarid, Nimrod</creatorcontrib><creatorcontrib>Gurevich, Tanya</creatorcontrib><creatorcontrib>Giladi, Nir</creatorcontrib><creatorcontrib>Shabtai, Hertzel</creatorcontrib><creatorcontrib>Zitser, Jennifer</creatorcontrib><creatorcontrib>Schilman, Eduardo A.</creatorcontrib><creatorcontrib>Sharon, Haggai</creatorcontrib><title>Reduced mind wandering in patients with Parkinson's disease</title><title>Parkinsonism & related disorders</title><addtitle>Parkinsonism Relat Disord</addtitle><description>Mind Wandering (MW) refers to the process of disengaging from the immediate external environment and participating in internally driven mentation. This process has been suggested to be supported by a distributed set of brain regions, collectively referred to as the Default Mode Network (DMN). Recently, reduced recruitment and connectivity of the DMN has been described in Parkinson's disease (PD) patients compared to healthy controls. We thus aimed to explore whether PD patients with normal cognitive test scores show differential MW capabilities compared to healthy controls.
Thirty PD patients and thirty age-matched controls, all with a Montreal cognitive assessment (MoCA) score of 26 or above, performed a novel yet validated thought-sampling paradigm used to assess the frequency and extent of MW irrespective of cognitive load in which participants were asked to observe a series of geometric shapes and describe their thoughts after watching them. Shapes were presented one at a time for varying durations across nine trials.
PD patients showed significantly less MW compared to the control. ANCOVA revealed a significant interaction indicating that the difference in MW scores was driven by trials with short stimulus presentation times.
These findings provide evidence for decreased MW in PD patients. We propose that this is due to difficulties in performing MW within short time frames.
•We examined whether Parkinson's patients display reduced mind wondering regardless of cognitive capabilities.•We found significantly less mind wandering in patients relative to healthy controls.•This difference was driven by trials with short stimulus presentation time.•This study is a potential first step in characterizing a new non-motor symptom in Parkinson's disease.</description><subject>Aged</subject><subject>Brain Mapping</subject><subject>Female</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mind wandering</subject><subject>Parkinson Disease - psychology</subject><subject>Parkinson's disease</subject><subject>Thinking</subject><issn>1353-8020</issn><issn>1873-5126</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0MtKxDAUBuAgipfRV5DudNN6ktgkgysVbyAoouuQy-mYsdPWpKP49kbGy9JVAvlP_sNHSEGhokDF0bwaTHyJ2PqQKgZUVqAq4LBGtqmSvKwpE-v5zmteKmCwRXZSmgOArIFvki2mlJSqltvk5AH90qEvFqHzxbvpPMbQzYrQFYMZA3ZjKt7D-Fzc58LQpb47SEVuRZNwl2w0pk24931OyNPlxeP5dXl7d3VzfnpbOj6VY8mskLZG72zDLRhfs_q45oCUuYZaVJYz5mQDx8YLI9i0YdzkRxTghBRI-YQcrv4dYv-6xDTqRUgO29Z02C-TplMuBGOKiRxVq6iLfUoRGz3EsDDxQ1PQX3R6rv_o9BedBqUzXR7d_25Z2gX638Efq79AmHmnbbBt6GfRDM_B6SnL1BNytgpgxngLGHVyWTDrhohu1L4P_6_xCf_lj3A</recordid><startdate>20171101</startdate><enddate>20171101</enddate><creator>Geffen, Tal</creator><creator>Thaler, Avner</creator><creator>Gilam, Gadi</creator><creator>Ben Simon, Eti</creator><creator>Sarid, Nimrod</creator><creator>Gurevich, Tanya</creator><creator>Giladi, Nir</creator><creator>Shabtai, Hertzel</creator><creator>Zitser, Jennifer</creator><creator>Schilman, Eduardo A.</creator><creator>Sharon, Haggai</creator><general>Elsevier Ltd</general><scope>AGDVQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3862-8288</orcidid></search><sort><creationdate>20171101</creationdate><title>Reduced mind wandering in patients with Parkinson's disease</title><author>Geffen, Tal ; Thaler, Avner ; Gilam, Gadi ; Ben Simon, Eti ; Sarid, Nimrod ; Gurevich, Tanya ; Giladi, Nir ; Shabtai, Hertzel ; Zitser, Jennifer ; Schilman, Eduardo A. ; Sharon, Haggai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-2b67b5edcbf3b0ad5254530e12cf1be8b322c7f04ad6a629f23ae12e60c676e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Brain Mapping</topic><topic>Female</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mind wandering</topic><topic>Parkinson Disease - psychology</topic><topic>Parkinson's disease</topic><topic>Thinking</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Geffen, Tal</creatorcontrib><creatorcontrib>Thaler, Avner</creatorcontrib><creatorcontrib>Gilam, Gadi</creatorcontrib><creatorcontrib>Ben Simon, Eti</creatorcontrib><creatorcontrib>Sarid, Nimrod</creatorcontrib><creatorcontrib>Gurevich, Tanya</creatorcontrib><creatorcontrib>Giladi, Nir</creatorcontrib><creatorcontrib>Shabtai, Hertzel</creatorcontrib><creatorcontrib>Zitser, Jennifer</creatorcontrib><creatorcontrib>Schilman, Eduardo A.</creatorcontrib><creatorcontrib>Sharon, Haggai</creatorcontrib><collection>IGDC Bibliographic Database - מאגר לחקר ההזדקנות</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Parkinsonism & related disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Geffen, Tal</au><au>Thaler, Avner</au><au>Gilam, Gadi</au><au>Ben Simon, Eti</au><au>Sarid, Nimrod</au><au>Gurevich, Tanya</au><au>Giladi, Nir</au><au>Shabtai, Hertzel</au><au>Zitser, Jennifer</au><au>Schilman, Eduardo A.</au><au>Sharon, Haggai</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced mind wandering in patients with Parkinson's disease</atitle><jtitle>Parkinsonism & related disorders</jtitle><addtitle>Parkinsonism Relat Disord</addtitle><date>2017-11-01</date><risdate>2017</risdate><volume>44</volume><issue>44</issue><spage>38</spage><epage>43</epage><pages>38-43</pages><issn>1353-8020</issn><eissn>1873-5126</eissn><abstract>Mind Wandering (MW) refers to the process of disengaging from the immediate external environment and participating in internally driven mentation. This process has been suggested to be supported by a distributed set of brain regions, collectively referred to as the Default Mode Network (DMN). Recently, reduced recruitment and connectivity of the DMN has been described in Parkinson's disease (PD) patients compared to healthy controls. We thus aimed to explore whether PD patients with normal cognitive test scores show differential MW capabilities compared to healthy controls.
Thirty PD patients and thirty age-matched controls, all with a Montreal cognitive assessment (MoCA) score of 26 or above, performed a novel yet validated thought-sampling paradigm used to assess the frequency and extent of MW irrespective of cognitive load in which participants were asked to observe a series of geometric shapes and describe their thoughts after watching them. Shapes were presented one at a time for varying durations across nine trials.
PD patients showed significantly less MW compared to the control. ANCOVA revealed a significant interaction indicating that the difference in MW scores was driven by trials with short stimulus presentation times.
These findings provide evidence for decreased MW in PD patients. We propose that this is due to difficulties in performing MW within short time frames.
•We examined whether Parkinson's patients display reduced mind wondering regardless of cognitive capabilities.•We found significantly less mind wandering in patients relative to healthy controls.•This difference was driven by trials with short stimulus presentation time.•This study is a potential first step in characterizing a new non-motor symptom in Parkinson's disease.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28877857</pmid><doi>10.1016/j.parkreldis.2017.08.030</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-3862-8288</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1353-8020 |
ispartof | Parkinsonism & related disorders, 2017-11, Vol.44 (44), p.38-43 |
issn | 1353-8020 1873-5126 |
language | eng |
recordid | cdi_proquest_miscellaneous_1936622826 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Aged Brain Mapping Female Humans Magnetic Resonance Imaging Male Middle Aged Mind wandering Parkinson Disease - psychology Parkinson's disease Thinking |
title | Reduced mind wandering in patients with Parkinson's disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T16%3A27%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20mind%20wandering%20in%20patients%20with%20Parkinson's%20disease&rft.jtitle=Parkinsonism%20&%20related%20disorders&rft.au=Geffen,%20Tal&rft.date=2017-11-01&rft.volume=44&rft.issue=44&rft.spage=38&rft.epage=43&rft.pages=38-43&rft.issn=1353-8020&rft.eissn=1873-5126&rft_id=info:doi/10.1016/j.parkreldis.2017.08.030&rft_dat=%3Cproquest_cross%3E1936622826%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1936622826&rft_id=info:pmid/28877857&rft_els_id=S1353802017303255&rfr_iscdi=true |